{"title": "PDF", "author": "PDF", "url": "https://www.uniklinik-freiburg.de/fileadmin/mediapool/09_zentren/cci/patienteninformationsblaetter/HLH_Deutsch_1019.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a01\u00a0von\u00a014\u00a0\u00a0\n\u00a0\nH\u00e4mophagozytose \u2010Syndrom/ \u00a0\nH\u00e4mophagozytische \u00a0Lymphohistiozytose \u00a0\n(HLH)\u00a0\n1. H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u2010\u00a0Was\u00a0ist\u00a0das?\u00a0\n2. Wie\u00a0h\u00e4ufig\u00a0ist\u00a0die\u00a0Erkrankung? \u00a0\n3. Ist\u00a0es\u00a0eine\u00a0Erbkrankheit? \u00a0\u00a0\n4. Krankheitszeichen: \u00a0Welche\u00a0Beschwerden \u00a0haben\u00a0Patienten \u00a0mit\u00a0einem\u00a0\nH\u00e4mophagozytose \u2010Syndrom? \u00a0\n5. Wie\u00a0wird\u00a0die\u00a0Erkrankung \u00a0festgestellt? \u00a0\n6. Welche\u00a0Behandlungsm\u00f6glichkeiten \u00a0gibt\u00a0es?\u00a0\n7. Wie\u00a0sieht\u00a0die\u00a0langfristige \u00a0Entwicklung \u00a0aus\u00a0(Prognose)? \u00a0\n8. Sind\u00a0Impfungen \u00a0erlaubt?\u00a0\n9. Kann\u00a0das\u00a0Kind\u00a0in\u00a0den\u00a0Kindergarten/ \u00a0die\u00a0Schule\u00a0gehen?\u00a0\n\u00a0\u00a0Informationsbl\u00e4tter \u00a0prim\u00e4re\u00a0Immundefekte\u00a0\nH\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a02\u00a0von\u00a014\u00a0Anmerkungen \u00a0zum\u00a0Text\u00a0\nDer\u00a0folgende\u00a0Informationstext \u00a0richtet\u00a0sich\u00a0an\u00a0Patienten, \u00a0die\u00a0von\u00a0einem\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0\nbetroffen \u00a0sind,\u00a0und\u00a0an\u00a0deren\u00a0Angeh\u00f6rige, \u00a0Freunde,\u00a0Lehrer\u00a0und\u00a0andere\u00a0Bezugspersonen \u00a0sowie\u00a0an\u00a0die\u00a0\ninteressierte \u00a0\u00d6ffentlichkeit. \u00a0Er\u00a0soll\u00a0dazu\u00a0beitragen, \u00a0diese\u00a0Erkrankung, \u00a0die\u00a0M\u00f6glichkeiten \u00a0ihrer\u00a0\nBehandlung \u00a0und\u00a0die\u00a0Probleme \u00a0und\u00a0besonderen \u00a0Bed\u00fcrfnisse \u00a0der\u00a0betroffenen \u00a0Patienten \u00a0besser\u00a0zu\u00a0\nverstehen. \u00a0\u00a0\nUnsere\u00a0Informationen \u00a0ersetzen\u00a0nicht\u00a0die\u00a0erforderlichen \u00a0kl\u00e4renden \u00a0Gespr\u00e4che \u00a0mit\u00a0den\u00a0behandelnden \u00a0\n\u00c4rzten\u00a0und\u00a0weiteren\u00a0Mitarbeitern \u00a0des\u00a0Behandlungsteams; \u00a0sie\u00a0k\u00f6nnen\u00a0aber\u00a0dabei\u00a0behilflich\u00a0sein,\u00a0\ndiese\u00a0Gespr\u00e4che \u00a0vorzubereiten \u00a0und\u00a0besser\u00a0zu\u00a0verstehen. \u00a0\nDie\u00a0in\u00a0diesem\u00a0Patiententext \u00a0enthaltenen \u00a0Informationen \u00a0sind\u00a0vor\u00a0allem\u00a0auf\u00a0der\u00a0Grundlage \u00a0der\u00a0unten\u00a0\nangegebenen \u00a0Literatur\u00a0sowie\u00a0unter\u00a0Ber\u00fccksichtigung \u00a0der\u00a0aktuellen \u00a0Leitlinie\u00a0zur\u00a0Behandlung \u00a0von\u00a0\nKindern\u00a0und\u00a0Jugendlichen \u00a0mit\u00a0einem\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0erstellt\u00a0worden.\u00a0Der\u00a0Text\u00a0wurde\u00a0\ndurch\u00a0die\u00a0oben\u00a0angegebenen \u00a0Editoren\u00a0im\u00a0August\u00a02019\u00a0\u00fcberpr\u00fcft \u00a0und\u00a0zur\u00a0Einstellung \u00a0ins\u00a0Internet\u00a0f\u00fcr\u00a0\ndie\u00a0Dauer\u00a0von\u00a0f\u00fcnf\u00a0Jahren\u00a0freigegeben. \u00a0Er\u00a0soll\u00a0sp\u00e4testens \u00a0nach\u00a0Ablauf\u00a0dieser\u00a0Frist\u00a0erneut\u00a0\u00fcberpr\u00fcft \u00a0\nund\u00a0aktualisiert \u00a0werden.\u00a0\nBitte\u00a0beachten \u00a0Sie,\u00a0dass\u00a0es\u00a0sich\u00a0im\u00a0Folgenden \u00a0um\u00a0allgemeine \u00a0Informationen \u00a0und\u00a0Empfehlungen \u00a0\nhandelt,\u00a0die\u00a0\u2013\u00a0aus\u00a0der\u00a0komplexen \u00a0Situation\u00a0heraus\u00a0\u2013\u00a0nicht\u00a0notwendigerweise \u00a0in\u00a0ihrer\u00a0Gesamtheit \u00a0bei\u00a0\njedem\u00a0Patienten \u00a0zutreffen. \u00a0Viele\u00a0Therapieempfehlungen \u00a0m\u00fcssen\u00a0im\u00a0Einzelfall\u00a0und\u00a0interdisziplin\u00e4r \u00a0\nentschieden \u00a0werden.\u00a0Ihr\u00a0Behandlungsteam \u00a0wird\u00a0Sie\u00a0\u00fcber\u00a0die\u00a0f\u00fcr\u00a0Sie\u00a0zutreffenden \u00a0Ma\u00dfnahmen \u00a0\ninformieren. \u00a0\n\u00a0 \u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a03\u00a0von\u00a014\u00a01. H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\u2010\u00a0Was\u00a0ist\u00a0das?\u00a0\nDas\u00a0H\u00e4mophagozytose \u2010Syndrom, \u00a0auch\u00a0als\u00a0H\u00e4mophagozytische \u00a0Lymphohistiozytose \u00a0(HLH)\u00a0bezeichnet, \u00a0\nsteht\u00a0f\u00fcr\u00a0eine\u00a0Gruppe\u00a0von\u00a0Erkrankungen \u00a0mit\u00a0einer\u00a0gest\u00f6rten \u00a0Regulation \u00a0des\u00a0Abwehrsystems \u00a0\n(Immunsystem). \u00a0Der\u00a0Name\u00a0H\u00e4mophagozytose \u00a0(H\u00e4mo\u00a0\u2013\u00a0vom\u00a0Griechischen \u00a0abgeleitet: \u00a0Blut)\u00a0beschreibt \u00a0\nein\u00a0wesentliches \u00a0Merkmal\u00a0der\u00a0Erkrankung: \u00a0Fresszellen \u00a0(Phagozyten \u00a0oder\u00a0Makrophagen), \u00a0die\u00a0zur\u00a0\nGruppe\u00a0der\u00a0wei\u00dfen\u00a0Blutk\u00f6rperchen \u00a0geh\u00f6ren\u00a0und\u00a0die\u00a0eine\u00a0wichtige\u00a0Rolle\u00a0bei\u00a0der\u00a0Bek\u00e4mpfung \u00a0von\u00a0\nKrankheitserregern \u00a0spielen,\u00a0\u201efressen\u201c \u00a0die\u00a0eigenen,\u00a0gesunden \u00a0Blutzellen. \u00a0Beim\u00a0H\u00e4mophagozytose \u2010\nSyndrom\u00a0(kurz:\u00a0HLH\u00a0f\u00fcr\u00a0H\u00e4mophagozytische \u00a0Lympho\u2010Histiozytose) \u00a0sind\u00a0die\u00a0Fresszellen \u00a0des\u00a0\nAbwehrsystems \u00a0stark\u00a0\u00fcberaktiviert. \u00a0Ihre\u00a0Aufgabe\u00a0ist\u00a0eigentlich \u00a0das\u00a0\u201eFressen\u201c \u00a0(Phagozytose) \u00a0von\u00a0\nKrankheitserregern \u00a0und\u00a0Zelltr\u00fcmmern. \u00a0Bei\u00a0der\u00a0HLH\u00a0vernichten \u00a0sie\u00a0aber\u00a0gesunde\u00a0Blutzellen \u00a0und\u00a0\nwandern\u00a0in\u00a0Organe\u00a0wie\u00a0die\u00a0Milz,\u00a0die\u00a0Leber\u00a0und\u00a0das\u00a0Zentralnervensystem \u00a0ein.\u00a0Dort\u00a0verursachen \u00a0sie\u00a0\nstarke\u00a0Entz\u00fcndungen, \u00a0wodurch\u00a0in\u00a0der\u00a0Folge\u00a0die\u00a0Milz\u00a0und\u00a0Leber\u00a0stark\u00a0anschwellen \u00a0und\u00a0Fieber\u00a0\nentsteht.\u00a0\n\u00a0\n2. Wie\u00a0h\u00e4ufig\u00a0ist\u00a0die\u00a0Erkrankung? \u00a0\nDas\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0ist\u00a0eine\u00a0seltene\u00a0Krankheit. \u00a0Es\u00a0tritt\u00a0in\u00a0Deutschland \u00a0bei\u00a0ungef\u00e4hr\u00a0ein\u00a0\nbis\u00a0zwei\u00a0von\u00a0100.000\u00a0Personen \u00a0auf.\u00a0Die\u00a0HLH\u2010Studie\u00a0der\u00a0Universit\u00e4tskliniken \u00a0Freiburg\u00a0und\u00a0Hamburg \u00a0\nsammelt\u00a0Daten\u00a0zu\u00a0Patienten \u00a0mit\u00a0einer\u00a0HLH\u00a0(HLH\u2010Register). \u00a0\n\u00a0\n3. Ist\u00a0es\u00a0eine\u00a0Erbkrankheit? \u00a0\nDas\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0ist\u00a0Folge\u00a0einer\u00a0unkontrollierten, \u00a0\u00fcberschie\u00dfenden \u00a0Immunreaktion. \u00a0\nHierdurch \u00a0entsteht\u00a0hohes\u00a0Fieber,\u00a0die\u00a0Lymphorgane \u00a0(Lymphknoten, \u00a0Milz\u00a0und\u00a0Leber)\u00a0schwellen \u00a0an\u00a0und\u00a0\nBlutzellen \u00a0werden\u00a0zerst\u00f6rt.\u00a0Wenn\u00a0diese\u00a0unkontrollierte \u00a0Immunreaktion \u00a0nicht\u00a0gestoppt\u00a0werden\u00a0kann,\u00a0\nkann\u00a0es\u00a0zu\u00a0einer\u00a0lebensbedrohlichen \u00a0Entz\u00fcndung \u00a0kommen, \u00a0die\u00a0den\u00a0ganzen\u00a0K\u00f6rper\u00a0betrifft.\u00a0Die\u00a0\nUrsachen \u00a0f\u00fcr\u00a0ein\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0sind\u00a0vielf\u00e4ltig,\u00a0und\u00a0h\u00e4ufig\u00a0gibt\u00a0es\u00a0mehrere\u00a0Faktoren, \u00a0die\u00a0\nzum\u00a0Ausbruch \u00a0der\u00a0Erkrankung \u00a0beitragen. \u00a0Man\u00a0unterscheidet \u00a0im\u00a0Wesentlichen \u00a0zwei\u00a0Formen\u00a0der\u00a0\nErkrankung: \u00a0eine\u00a0angeborene \u00a0Form\u00a0(prim\u00e4re\u00a0HLH\u00a0oder\u00a0famili\u00e4re\u00a0HLH\u00a0=\u00a0FHL)\u00a0und\u00a0eine\u00a0erworbene \u00a0\nForm\u00a0(sekund\u00e4re \u00a0HLH),\u00a0die\u00a0nicht\u00a0angeboren \u00a0ist.\u00a0\n\u00a0\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a04\u00a0von\u00a014\u00a0Prim\u00e4re\u00a0HLH:\u00a0\nBei\u00a0der\u00a0prim\u00e4ren \u00a0HLH\u00a0liegt\u00a0eine\u00a0genetische \u00a0Veranlagung \u00a0vor,\u00a0die\u00a0die\u00a0Entstehung \u00a0einer\u00a0HLH\u00a0\nbeg\u00fcnstigt. \u00a0In\u00a0der\u00a0Regel\u00a0sind\u00a0Gene\u00a0betroffen, \u00a0die\u00a0f\u00fcr\u00a0das\u00a0Begrenzen \u00a0von\u00a0Immunantworten \u00a0notwendig \u00a0\nsind.\u00a0Das\u00a0bedeutet, \u00a0dass\u00a0betroffene \u00a0Patienten \u00a0in\u00a0der\u00a0Regel\u00a0bei\u00a0Geburt\u00a0und\u00a0in\u00a0den\u00a0ersten\u00a0\nLebensmonaten \u00a0(manchmal \u00a0\u00fcber\u00a0Jahre)\u00a0keine\u00a0klinischen \u00a0Symptome \u00a0haben.\u00a0Wenn\u00a0aber\u00a0das\u00a0\nImmunsystem \u00a0stark\u00a0stimuliert \u00a0wird,\u00a0reagiert\u00a0es\u00a0\u00fcberschie\u00dfend \u00a0und\u00a0kommt\u00a0nicht\u00a0mehr\u00a0zur\u00a0Ruhe\u00a0mit\u00a0\nder\u00a0Folge\u00a0einer\u00a0sehr\u00a0starken\u00a0Entz\u00fcndungsreaktion \u00a0und\u00a0\u00dcberaktivierung \u00a0Immunzellen, \u00a0vor\u00a0allem\u00a0von\u00a0\nLymphozyten \u00a0und\u00a0Makrophagen \u00a0(Fresszellen). \u00a0Der\u00a0Krankheitsbeginn \u00a0ist\u00a0oft\u00a0im\u00a0ersten\u00a0Lebensjahr. \u00a0\u00a0\nDie\u00a0meisten\u00a0Formen\u00a0der\u00a0prim\u00e4ren \u00a0HLH\u00a0werden\u00a0autosomal \u2010rezessiv\u00a0vererbt.\u00a0Hierzu\u00a0geh\u00f6rt\u00a0die\u00a0FHL\u2010\nErkrankungen \u00a0(FHL2\u00a0=\u00a0Perforin\u2010Defekt,\u00a0FHL3\u00a0=\u00a0Munc\u00a013\u20104\u00a0Defekt\u00a0oder\u00a0FHL4\u00a0=\u00a0Syntaxin\u00a011\u00a0Defekt),\u00a0\ndas\u00a0Chediak\u2010Higashi\u2010Syndrom\u00a0und\u00a0das\u00a0Griscelli\u2010Syndrom\u00a0Typ\u00a02.\u00a0Das\u00a0bedeutet, \u00a0dass\u00a0beide\u00a0Elternteile \u00a0\nklinisch\u00a0gesunde\u00a0Tr\u00e4ger\u00a0des\u00a0defekten\u00a0Gens\u00a0sind,\u00a0d.h.\u00a0beide\u00a0haben\u00a0neben\u00a0dem\u00a0krankmachenden \u00a0auch\u00a0\nein\u00a0gesundes \u00a0Gen,\u00a0das\u00a0ausreicht, \u00a0um\u00a0vor\u00a0der\u00a0Erkrankung \u00a0zu\u00a0sch\u00fctzen. \u00a0F\u00fcr\u00a0die\u00a0Nachkommen \u00a0entsteht\u00a0\ndadurch\u00a0eine\u00a0Erkrankungswahrscheinlichkeit \u00a0von\u00a025\u00a0%.\u00a0Der\u00a0Krankheitsbeginn \u00a0liegt\u00a0meist\u00a0schon\u00a0im\u00a0\nersten\u00a0Lebensjahr. \u00a0\nAuch\u00a0die\u00a0X\u2010chromosomale \u00a0lymphoproliferative \u00a0Erkrankung \u00a0(kurz:\u00a0XLP,\u00a0auch\u00a0Purtilo\u2010Syndrom\u00a0genannt)\u00a0\ngeht\u00a0mit\u00a0einem\u00a0hohen\u00a0Risiko\u00a0f\u00fcr\u00a0HLH\u00a0einher.\u00a0XLP\u00a0gibt\u00a0es\u00a0in\u00a0zwei\u00a0Varianten, \u00a0bei\u00a0beiden\u00a0entsteht\u00a0die\u00a0\nHLH\u00a0oft\u00a0im\u00a0Zusammenhang \u00a0mit\u00a0einer\u00a0Infektion\u00a0durch\u00a0Epstein\u2010Barr\u2010Virus\u00a0(EBV).\u00a0XLP1\u00a0hat\u00a0zus\u00e4tzlich \u00a0ein\u00a0\nhohes\u00a0Risiko\u00a0f\u00fcr\u00a0Infektionsanf\u00e4lligkeit \u00a0und\u00a0Lymphdr\u00fcsenkrebs, \u00a0XLP2\u00a0hat\u00a0ein\u00a0hohes\u00a0Risiko\u00a0f\u00fcr\u00a0\nentz\u00fcndliche \u00a0Darmerkrankung \u00a0und\u00a0andere\u00a0Entz\u00fcndungen. \u00a0Der\u00a0Krankheitsbeginn \u00a0ist\u00a0bei\u00a0XLP\u00a0oft\u00a0\njenseits\u00a0des\u00a0ersten\u00a0Lebensjahres, \u00a0kann\u00a0aber\u00a0auch\u00a0im\u00a0S\u00e4uglingsalter \u00a0auftreten. \u00a0\nBei\u00a0der\u00a0X\u2010chromosomalen \u00a0lymphoproliferativen \u00a0Erkrankung \u00a0liegt\u00a0ein\u00a0anderer\u00a0Vererbungsgang \u00a0vor.\u00a0\nDas\u00a0betroffene \u00a0Gen\u00a0liegt\u00a0auf\u00a0dem\u00a0X\u2010Chromosom \u00a0und\u00a0wird\u00a0daher\u00a0geschlechtsgebunden \u00a0vererbt.\u00a0Hier\u00a0\nist\u00a0meist\u00a0die\u00a0Mutter\u00a0Tr\u00e4gerin\u00a0des\u00a0kranken\u00a0Gens,\u00a0welches\u00a0aber\u00a0bei\u00a0der\u00a0Mutter\u00a0durch\u00a0ein\u00a0gesundes \u00a0Gen\u00a0\nauf\u00a0dem\u00a0zweiten\u00a0X\u2010Chromosom \u00a0ausgeglichen \u00a0wird.\u00a0Jungen\u00a0haben\u00a0nur\u00a0ein\u00a0X\u2010Chromosom, \u00a0das\u00a0sie\u00a0als\u00a0\neines\u00a0von\u00a0zwei\u00a0m\u00fctterlichen \u00a0X\u2010Chromosomen \u00a0zuf\u00e4llig\u00a0von\u00a0der\u00a0Mutter\u00a0erben.\u00a0Wenn\u00a0sie\u00a0das\u00a0X\u2010\nChromosom \u00a0mit\u00a0dem\u00a0kranken\u00a0Gen\u00a0erben,\u00a0tritt\u00a0die\u00a0Krankheit \u00a0auf,\u00a0da\u00a0sie\u00a0diese\u00a0nicht\u00a0mit\u00a0einem\u00a0zweiten\u00a0\ngesunden \u00a0Gen\u00a0ausgleichen \u00a0k\u00f6nnen.\u00a0Bei\u00a0diesem\u00a0Erbgang\u00a0ist\u00a0die\u00a0H\u00e4lfte\u00a0aller\u00a0Jungen\u00a0von\u00a0der\u00a0Krankheit \u00a0\nbetroffen, \u00a0w\u00e4hrend\u00a0die\u00a0M\u00e4dchen \u00a0alle\u00a0gesund\u00a0sind.\u00a0Die\u00a0H\u00e4lfte\u00a0der\u00a0M\u00e4dchen \u00a0kann\u00a0allerdings \u00a0die\u00a0\nKrankheit \u00a0wieder\u00a0an\u00a0ihre\u00a0eigenen\u00a0m\u00e4nnlichen \u00a0Kinder\u00a0\u00fcbertragen. \u00a0In\u00a0diesem\u00a0Fall\u00a0spricht\u00a0man\u00a0von\u00a0\nKonduktorinnen: \u00a0Die\u00a0\u00dcbertr\u00e4gerinnen \u00a0der\u00a0Erkrankungen \u00a0sind\u00a0selbst\u00a0gesund,\u00a0ihre\u00a0m\u00e4nnlichen \u00a0\nNachkommen \u00a0hingegen\u00a0k\u00f6nnen\u00a0erkranken. \u00a0\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a05\u00a0von\u00a014\u00a0Bei\u00a0allen\u00a0angeborenen, \u00a0prim\u00e4ren \u00a0Formen\u00a0ist\u00a0der\u00a0Bauplan\u00a0(Gen)\u00a0f\u00fcr\u00a0ein\u00a0Eiwei\u00df\u00a0(Protein)\u00a0fehlerhaft, \u00a0so\u00a0\ndass\u00a0das\u00a0Protein\u00a0nicht\u00a0mehr\u00a0in\u00a0der\u00a0richtigen\u00a0Form\u00a0oder\u00a0gar\u00a0nicht\u00a0mehr\u00a0gebildet\u00a0werden\u00a0kann.\u00a0\nVerschiedene \u00a0Gendefekte \u00a0k\u00f6nnen\u00a0die\u00a0Ursache\u00a0f\u00fcr\u00a0das\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0sein.\u00a0Meistens\u00a0\nliegt\u00a0ein\u00a0Defekt\u00a0in\u00a0den\u00a0Genen\u00a0f\u00fcr\u00a0Perforin,\u00a0Munc\u00a013\u20104\u00a0oder\u00a0Syntaxin\u00a011\u00a0vor.\u00a0Bis\u00a0heute\u00a0sind\u00a0aber\u00a0nicht\u00a0\nalle\u00a0genetischen \u00a0Ursachen \u00a0f\u00fcr\u00a0die\u00a0verschiedenen \u00a0FHL\u2010Varianten \u00a0bekannt.\u00a0\u00a0\nWird\u00a0eine\u00a0prim\u00e4re\u00a0HLH\u00a0diagnostiziert, \u00a0sollte\u00a0immer\u00a0eine\u00a0genetische \u00a0Familienberatung \u00a0durchgef\u00fchrt \u00a0\nwerden.\u00a0\nSekund\u00e4re \u00a0HLH:\u00a0\nDie\u00a0sekund\u00e4ren \u00a0Formen\u00a0des\u00a0H\u00e4mophagozytose \u2010Syndroms \u00a0k\u00f6nnen\u00a0alle\u00a0Altersklassen \u00a0betreffen \u00a0und\u00a0\nsind\u00a0am\u00a0h\u00e4ufigsten \u00a0nach\u00a0Infektionen, \u00a0vor\u00a0allem\u00a0nach\u00a0(Virus)\u2010Infektionen \u00a0wie\u00a0dem\u00a0Epstein\u2010Barr\u2010Virus\u00a0\n(EBV\u2010Infektion\u00a0=\u00a0Pfeiffer\u2019sches \u00a0Dr\u00fcsenfieber), \u00a0Cytomegalievirus \u00a0(CMV)\u00a0u)\u00a0oder\u00a0z.B.\u00a0nach\u00a0einer\u00a0\nLeishmanieninfektion \u00a0zu\u00a0beobachten. \u00a0Aber\u00a0auch\u00a0Kinder\u00a0mit\u00a0b\u00f6sartigen \u00a0(malignen) \u00a0Erkrankungen \u00a0oder\u00a0\nsystemischen \u00a0rheumatologischen \u00a0Erkrankungen, \u00a0z.B.\u00a0dem\u00a0Morbus\u00a0Still\u00a0oder\u00a0Systemischer \u00a0Lupus\u00a0\nErythematodes, \u00a0Stoffwechseldefekten \u00a0oder\u00a0Immundefekten \u00a0k\u00f6nnen\u00a0von\u00a0H\u00e4mophagozytose \u2010Episoden\u00a0\nbetroffen \u00a0sein.\u00a0\u00a0\nAuch\u00a0einzelne\u00a0Medikamente \u00a0k\u00f6nnen\u00a0in\u00a0seltenen\u00a0F\u00e4llen\u00a0eine\u00a0HLH\u00a0als\u00a0unerw\u00fcnschte \u00a0Nebenwirkung \u00a0\nausl\u00f6sen\u00a0(zum\u00a0Beispiel\u00a0das\u00a0Antiepileptikum \u00a0Lamotrigin \u00a0und\u00a0das\u00a0Immussuppressivum \u00a0Fingolimod). \u00a0\nDie\u00a0sekund\u00e4re \u00a0HLH\u00a0ist\u00a0nicht\u00a0vererbt\u00a0und\u00a0tritt\u00a0daher\u00a0nicht\u00a0geh\u00e4uft\u00a0in\u00a0Familien\u00a0auf.\u00a0\n\u00a0\n4. Krankheitszeichen: \u00a0Welche\u00a0Beschwerden \u00a0haben\u00a0Patienten \u00a0mit\u00a0einem\u00a0\nH\u00e4mophagozytose \u2010Syndrom? \u00a0\nDie\u00a0Krankheitszeichen \u00a0(Symptome) \u00a0des\u00a0H\u00e4mophagozytose \u2010Syndroms \u00a0sind\u00a0vielf\u00e4ltig,\u00a0da\u00a0verschiedene \u00a0\nOrgansysteme \u00a0von\u00a0der\u00a0Erkrankung \u00a0betroffen \u00a0sein\u00a0k\u00f6nnen.\u00a0Das\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0ist\u00a0eine\u00a0\nlebensbedrohliche \u00a0Erkrankung \u00a0und\u00a0ein\u00a0immunologischer \u00a0Notfall.\u00a0Kinder\u00a0mit\u00a0der\u00a0angeborenen \u00a0Form\u00a0\neiner\u00a0FLH\u00a0k\u00f6nnen\u00a0immer\u00a0wieder\u00a0schwere\u00a0Krankheitssch\u00fcbe \u00a0erleiden,\u00a0bei\u00a0Kindern\u00a0mit\u00a0sekund\u00e4rer \u00a0HLH\u00a0\nist\u00a0das\u00a0Risiko\u00a0von\u00a0erneuten \u00a0Krankheitssch\u00fcben \u00a0gering.\u00a0Direkte\u00a0Ausl\u00f6ser\u00a0sind\u00a0bei\u00a0\u00e4lteren\u00a0Kindern\u00a0meist\u00a0\n(virale)\u00a0Infektionen, \u00a0bei\u00a0S\u00e4uglingen \u00a0wird\u00a0oft\u00a0keine\u00a0ausl\u00f6sende \u00a0Infektion\u00a0gefunden. \u00a0\n\u00a0\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a06\u00a0von\u00a014\u00a0Immunsystem \u00a0(Fieber):\u00a0\nWenn\u00a0das\u00a0Abwehrsystem \u00a0beispielsweise \u00a0durch\u00a0eine\u00a0Infektion\u00a0angeregt\u00a0wird,\u00a0ist\u00a0Fieber\u00a0zun\u00e4chst\u00a0eine\u00a0\nnormale\u00a0Reaktion\u00a0des\u00a0K\u00f6rpers.\u00a0Es\u00a0entsteht\u00a0durch\u00a0die\u00a0Freisetzung \u00a0von\u00a0entz\u00fcndlichen \u00a0Botenstoffen \u00a0\ndurch\u00a0Immunzellen, \u00a0die\u00a0die\u00a0Abwehrreaktion \u00a0des\u00a0K\u00f6rpers\u00a0vermitteln. \u00a0Bei\u00a0der\u00a0HLH\u00a0kommt\u00a0das\u00a0\nImmunsystem \u00a0trotz\u00a0Abklingen \u00a0der\u00a0Infektion\u00a0nicht\u00a0zur\u00a0Ruhe.\u00a0Die\u00a0Fieberreaktion \u00a0h\u00f6rt\u00a0nicht\u00a0mehr\u00a0auf,\u00a0\ndie\u00a0Abwehrzellen \u00a0bleiben\u00a0hochaktiv, \u00a0auch\u00a0wenn\u00a0die\u00a0Infektion\u00a0eigentlich \u00a0\u00fcberstanden \u00a0ist.\u00a0Das\u00a0Fieber\u00a0\nist\u00a0nicht\u00a0immer\u00a0gleichbleibend \u00a0hoch,\u00a0sondern\u00a0zeigt\u00a0h\u00e4ufig\u00a0einen\u00a0\u201ewellenf\u00f6rmigen\u201c \u00a0Verlauf,\u00a0kann\u00a0aber\u00a0\nauch\u00a0nach\u00a0einiger\u00a0Zeit\u00a0nachlassen \u00a0oder\u00a0ganz\u00a0zur\u00fcckgehen. \u00a0\nLeber\u00a0und\u00a0Milz:\u00a0\nIm\u00a0Rahmen\u00a0der\u00a0\u00fcberschie\u00dfenden \u00a0Immunreaktion \u00a0vermehren \u00a0sich\u00a0vor\u00a0allem\u00a0T\u2010Lymphozyten \u00a0und\u00a0\nwerden\u00a0in\u00a0gro\u00dfer\u00a0Zahl\u00a0aktiviert.\u00a0Diese\u00a0wandern\u00a0auch\u00a0in\u00a0die\u00a0Milz\u00a0und\u00a0die\u00a0Leber\u00a0und\u00a0aktivieren \u00a0dort\u00a0die\u00a0\nans\u00e4ssigen \u00a0Fresszellen \u00a0(Makrophagen). \u00a0In\u00a0der\u00a0Folge\u00a0kommt\u00a0es\u00a0zu\u00a0einer\u00a0fortschreitenden \u00a0\nVergr\u00f6\u00dferung \u00a0dieser\u00a0Organe\u00a0(Milz:\u00a0Splenomegalie, \u00a0Leber:\u00a0Hepatomegalie). \u00a0\nDurch\u00a0die\u00a0Beteiligung \u00a0der\u00a0Leber\u00a0kann\u00a0es\u00a0auch\u00a0zu\u00a0einer\u00a0Gelbf\u00e4rbung \u00a0der\u00a0Haut\u00a0(Ikterus),\u00a0einer\u00a0Erh\u00f6hung \u00a0\nder\u00a0Leberenzyme \u00a0(Transaminasen) \u00a0und\u00a0der\u00a0Blutfette, \u00a0einem\u00a0Eiwei\u00dfmangel \u00a0(Albuminmangel) \u00a0im\u00a0Blut\u00a0\nund\u00a0einem\u00a0Verschluss \u00a0der\u00a0Gallenwege \u00a0kommen. \u00a0\nZentralnervensystem: \u00a0\nOft\u00a0ist\u00a0auch\u00a0das\u00a0Gehirn\u00a0von\u00a0der\u00a0unkontrollierten \u00a0Entz\u00fcndungsreaktion \u00a0betroffen. \u00a0Symptome, \u00a0die\u00a0auf\u00a0\neine\u00a0Beteiligung \u00a0des\u00a0Zentralnervensystems \u00a0hinweisen, \u00a0k\u00f6nnen\u00a0sehr\u00a0variabel\u00a0sein.\u00a0Sie\u00a0k\u00f6nnen\u00a0von\u00a0\nAnfang\u00a0an\u00a0das\u00a0sichtbare \u00a0Krankheitsbild \u00a0bestimmen, \u00a0treten\u00a0h\u00e4ufig\u00a0aber\u00a0erst\u00a0im\u00a0weiteren\u00a0\nKrankheitsverlauf \u00a0auf.\u00a0Die\u00a0Kinder\u00a0sind\u00a0schlapp,\u00a0teilnahmslos \u00a0und\u00a0reagieren \u00a0auf\u00a0ihr\u00a0Umfeld\u00a0nur\u00a0wenig\u00a0\noder\u00a0gar\u00a0nicht.\u00a0Andere\u00a0haben\u00a0eine\u00a0erh\u00f6hte\u00a0Zittrigkeit, \u00a0zeigen\u00a0eine\u00a0ausgepr\u00e4gte \u00a0\u00dcberstreckung \u00a0des\u00a0\nKopfes\u00a0nach\u00a0hinten\u00a0und\u00a0eine\u00a0erh\u00f6hte\u00a0oder\u00a0erniedrigte \u00a0Muskelspannung \u00a0Bei\u00a0manchen \u00a0S\u00e4uglingen \u00a0ist\u00a0\ndie\u00a0Fontanelle \u00a0gespannt \u00a0und\u00a0vorgew\u00f6lbt, \u00a0sie\u00a0schreien\u00a0schrill,\u00a0sind\u00a0lichtempfindlich, \u00a0erbrechen \u00a0\nvermehrt \u00a0und\u00a0haben\u00a0eine\u00a0Nackensteifigkeit \u00a0(Meningismus). \u00a0In\u00a0einigen\u00a0F\u00e4llen\u00a0k\u00f6nnen\u00a0die\u00a0\nneurologischen \u00a0Krankheitszeichen \u00a0ausgepr\u00e4gt \u00a0sein\u00a0und\u00a0im\u00a0Verlauf\u00a0auch\u00a0zu\u00a0einem\u00a0Krampfanfall \u00a0\nf\u00fchren.\u00a0\nBei\u00a0Kindern\u00a0mit\u00a0dem\u00a0Chediak\u2010Higashi\u2013Syndrom \u00a0kann\u00a0es\u00a0auch\u00a0unabh\u00e4ngig \u00a0von\u00a0der\u00a0HLH\u00a0zu\u00a0vielf\u00e4ltigen \u00a0\nneurologischen \u00a0Symptomen \u00a0wie\u00a0einer\u00a0Entwicklungsverz\u00f6gerung \u00a0und/oder \u00a0einer\u00a0Muskelschw\u00e4che \u00a0\nkommen. \u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a07\u00a0von\u00a014\u00a0Blut\u00a0(Zytopenie) \u00a0und\u00a0Blutgerinnung: \u00a0\nAuch\u00a0die\u00a0Zahl\u00a0der\u00a0Blutzellen \u00a0ist\u00a0bei\u00a0den\u00a0Patienten \u00a0erniedrigt \u00a0(Zytopenie). \u00a0Das\u00a0k\u00f6nnen\u00a0die\u00a0roten\u00a0\nBlutzellen \u00a0sein\u00a0(Erythrozytopenie), \u00a0was\u00a0sich\u00a0in\u00a0einer\u00a0An\u00e4mie\u00a0(Krankheitszeichen: \u00a0Hautbl\u00e4sse, \u00a0\nM\u00fcdigkeit, \u00a0(Trink\u2010)\u00a0Schw\u00e4che, \u00a0Luftnot,\u00a0Leistungsminderung, \u00a0R\u00fccken\u2010\u00a0oder\u00a0Kopfschmerzen) \u00a0zeigt,\u00a0die\u00a0\nBlutpl\u00e4ttchen \u00a0(Thrombozytopenie) \u00a0und\u00a0andere\u00a0Blutgerinnungsfaktoren, \u00a0die\u00a0f\u00fcr\u00a0die\u00a0Blutgerinnung \u00a0mit\u00a0\nverantwortlich \u00a0sind\u00a0(Krankheitszeichen \u00a0z.B.\u00a0kleine\u00a0punktf\u00f6rmige \u00a0Haut\u2010\u00a0oder\u00a0Schleimhautblutungen, \u00a0\nH\u00e4matome) \u00a0und/oder \u00a0die\u00a0neutrophilen \u00a0Granulozyten \u00a0(Neutropenie) \u00a0sein,\u00a0die\u00a0eine\u00a0entscheidende \u00a0\nRolle\u00a0bei\u00a0der\u00a0Abwehr\u00a0von\u00a0Krankheitserregern \u00a0spielen\u00a0(Krankheitszeichen: \u00a0bakterielle \u00a0Infektionen). \u00a0\nMagen\u00a0und\u00a0Darm:\u00a0\nDer\u00a0Beginn\u00a0eines\u00a0H\u00e4mophagozytose \u2010Syndroms \u00a0ist\u00a0oftmals\u00a0gekennzeichnet \u00a0durch\u00a0Durchfall\u00a0und\u00a0\nBauchschmerzen, \u00a0\u00dcbelkeit\u00a0und\u00a0Erbrechen. \u00a0Bei\u00a0der\u00a0FHL5\u00a0und\u00a0der\u00a0XLP2\u00a0Erkrankung \u00a0kann\u00a0es\u00a0zu\u00a0\nschweren \u00a0Durchf\u00e4llen \u00a0kommen, \u00a0die\u00a0nur\u00a0schwer\u00a0durch\u00a0Medikamente \u00a0zu\u00a0kontrollieren \u00a0sind.\u00a0\nHaut:\u00a0\nBei\u00a0einigen\u00a0Kindern\u00a0kommt\u00a0es\u00a0zu\u00a0einem\u00a0unspezifischen \u00a0Hautausschlag. \u00a0Sind\u00a0die\u00a0Blutpl\u00e4ttchen \u00a0stark\u00a0\nerniedrigt, \u00a0kann\u00a0es\u00a0zu\u00a0kleinen\u00a0punktf\u00f6rmigen \u00a0Einblutungen \u00a0in\u00a0die\u00a0Haut\u00a0kommen\u00a0(Petechien, \u00a0Purpura). \u00a0\nBei\u00a0Kindern\u00a0mit\u00a0einer\u00a0starken\u00a0Mitbeteiligung \u00a0der\u00a0Leber\u00a0k\u00f6nnen\u00a0sich\u00a0Wassereinlagerungen \u00a0in\u00a0das\u00a0\nGewebe,\u00a0sogenannte \u00a0\u00d6deme,\u00a0entwickeln, \u00a0wenn\u00a0der\u00a0Albumingehalt \u00a0im\u00a0Blut\u00a0zu\u00a0niedrig\u00a0ist.\u00a0\nZus\u00e4tzlich \u00a0zu\u00a0den\u00a0oben\u00a0erw\u00e4hnten \u00a0Symptomen \u00a0kommt\u00a0es\u00a0beim\u00a0Chediak\u2010Higashi\u2010Syndrom\u00a0und\u00a0\nGriscelli\u2010Syndrom\u00a0zu\u00a0einer\u00a0unterschiedlich \u00a0stark\u00a0ausgepr\u00e4gten \u00a0Pigmentst\u00f6rung, \u00a0einem\u00a0partiellen \u00a0\nAlbinismus \u00a0(Fehlen\u00a0von\u00a0Pigmenten). \u00a0Dieser\u00a0ist\u00a0am\u00a0deutlichsten \u00a0an\u00a0den\u00a0Haaren,\u00a0Augenbrauen \u00a0und\u00a0\nWimpern \u00a0(blonde\u00a0bis\u00a0gr\u00e4ulich\u00a0schimmernde \u00a0Haare),\u00a0der\u00a0\u201ehellrosafarbigen\u201c \u00a0Haut\u00a0und\u00a0der\u00a0hellblau\u00a0\noder\u00a0r\u00f6tlich\u00a0schimmernden \u00a0Regenbogenhaut \u00a0des\u00a0Auges\u00a0zu\u00a0erkennen. \u00a0\nLunge:\u00a0\nEine\u00a0Beteiligung \u00a0der\u00a0Lungen\u00a0kann\u00a0sich\u00a0in\u00a0Form\u00a0von\u00a0Gewebswassereinlagerungen \u00a0in\u00a0das\u00a0Lungenfell \u00a0\n(Pleuraerguss) \u00a0und/oder \u00a0in\u00a0die\u00a0Lunge\u00a0(Lungen\u00f6dem) \u00a0\u00e4u\u00dfern.\u00a0Ursache\u00a0hierf\u00fcr\u00a0kann\u00a0auch\u00a0ein\u00a0\nerniedrigter \u00a0Albumingehalt \u00a0im\u00a0Blut\u00a0sein.\u00a0\n\u00a0\n\u00a0 \u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a08\u00a0von\u00a014\u00a05. Wie\u00a0wird\u00a0die\u00a0Erkrankung \u00a0festgestellt? \u00a0\nUm\u00a0eine\u00a0HLH\u2010Erkrankung \u00a0festzustellen, \u00a0sind\u00a0zun\u00e4chst\u00a0eine\u00a0sorgf\u00e4ltige \u00a0k\u00f6rperliche \u00a0Untersuchung \u00a0\nsowie\u00a0eine\u00a0genaue\u00a0Erhebung \u00a0der\u00a0Anamnese \u00a0(Krankheitsgeschichte) \u00a0unter\u00a0Mitbeurteilung \u00a0der\u00a0\nFamiliengeschichte \u00a0(wie\u00a0zum\u00a0Beispiel\u00a0Blutsverwandtschaft, \u00a0bekannter \u00a0Immundefekt \u00a0in\u00a0der\u00a0\nFamiliengeschichte) \u00a0von\u00a0Bedeutung. \u00a0Sie\u00a0k\u00f6nnen\u00a0eine\u00a0erste\u00a0Auskunft\u00a0geben,\u00a0wie\u00a0stark\u00a0der\u00a0\nKrankheitsschub \u00a0ist\u00a0und\u00a0ob\u00a0es\u00a0sich\u00a0um\u00a0eine\u00a0prim\u00e4re\u00a0oder\u00a0sekund\u00e4re \u00a0Form\u00a0der\u00a0HLH\u00a0handelt\u00a0(siehe\u00a0\nKapitel:\u00a0Ursachen \u00a0der\u00a0HLH)\u00a0\u00a0\nEs\u00a0gibt\u00a0keine\u00a0spezifischen \u00a0Untersuchungen \u00a0oder\u00a0einen\u00a0Test,\u00a0die\u00a0die\u00a0Diagnose\u00a0eines\u00a0\nH\u00e4mophagozytose \u2010Syndroms \u00a0belegen\u00a0oder\u00a0widerlegen \u00a0k\u00f6nnten.\u00a0\nGem\u00e4\u00df\u00a0der\u00a0europ\u00e4ischen \u00a0Studiengruppe \u00a0HLH\u00a02004,\u00a0die\u00a0sich\u00a0den\u00a0angeborenen \u00a0H\u00e4mophagozytose \u2010\nSyndromen \u00a0widmet,\u00a0basiert\u00a0die\u00a0Diagnose \u00a0auf\u00a0dem\u00a0Vorhandensein \u00a0von\u00a0mindestens \u00a05\u00a0der\u00a0folgenden \u00a0\n8\u00a0Kriterien \u00a0\n\uf0b7 Fieber\u00a0\n\uf0b7 Vergr\u00f6\u00dferung \u00a0der\u00a0Milz\u00a0(Splenomegalie) \u00a0\n\uf0b7 Erniedrigung \u00a0von\u00a0mindestens \u00a0zwei\u00a0Blutzellreihen: \u00a0H\u00e4moglobin \u00a0<\u00a09,0\u00a0g/dl\u00a0(bei\u00a0Neugeborenen \u00a0<\u00a010\u00a0\ng/dl),\u00a0Thrombozyten \u00a0<\u00a0100.000/\u00b5, \u00a0neutrophile \u00a0Granulozyten \u00a0<\u00a01000/\u00b5l\u00a0\n\uf0b7 Erh\u00f6hung \u00a0der\u00a0Blutfette\u00a0(Hypertriglycerid\u00e4mie, \u00a0>=\u00a03mmol/l) \u00a0n\u00fcchtern\u00a0und/oder \u00a0Erniedrigung \u00a0des\u00a0\nGerinnungsfaktors \u00a0Fibrinogen \u00a0im\u00a0Blut\u00a0(Hypofibrinogen\u00e4mie \u00a0(<\u00a01.5\u00a0g/l)\u00a0\n\uf0b7 Mikroskopischer \u00a0Nachweis \u00a0der\u00a0Aufnahme \u00a0von\u00a0Blutzellen \u00a0durch\u00a0Makrophagen \u00a0\n(H\u00e4mophagozytose) \u00a0im\u00a0Knochenmark, \u00a0in\u00a0Milz\u00a0oder\u00a0Lymphknoten \u00a0\n\uf0b7 Erh\u00f6hung \u00a0des\u00a0Speicherstoffs \u00a0f\u00fcr\u00a0Eisen\u00a0Ferritin\u00a0(Hyperferritin\u00e4mie \u00a0<=500\u00a0\u03bcg/l)\u00a0\n\uf0b7 Erh\u00f6hter\u00a0Spiegel\u00a0von\u00a0l\u00f6slichem \u00a0CD25\u00a0(2400\u00a0UI/ml),\u00a0als\u00a0Zeichen\u00a0einer\u00a0\u00fcberschie\u00dfenden \u00a0\nEntz\u00fcndungsreaktion \u00a0im\u00a0K\u00f6rper\u00a0\n\uf0b7 Defekt\u00a0der\u00a0NK\u2010Zellen\u00a0(Nat\u00fcrliche \u00a0Killerzellen) \u00a0\nW\u00e4hrend \u00a0eines\u00a0H\u00e4mophagozytose \u2010Syndroms \u00a0kommt\u00a0es\u00a0zur\u00a0\u00fcberschie\u00dfenden \u00a0Aktivierung \u00a0und\u00a0\nVermehrung \u00a0von\u00a0T\u2010Zellen.\u00a0Diese\u00a0Zellen\u00a0k\u00f6nnen\u00a0praktisch\u00a0in\u00a0alle\u00a0Organe\u00a0einwandern \u00a0und\u00a0durch\u00a0die\u00a0\nvermehrte \u00a0Aussch\u00fcttung \u00a0von\u00a0Zytokinen \u00a0eine\u00a0derart\u00a0starke\u00a0Aktivierung \u00a0der\u00a0Makrophagen \u00a0bewirken, \u00a0\ndass\u00a0diese\u00a0beginnen, \u00a0andere\u00a0Blutzellen \u00a0aufzufressen \u00a0(zu\u00a0phagozytieren), \u00a0was\u00a0zum\u00a0Bild\u00a0der\u00a0\nH\u00e4mophagozytose \u00a0f\u00fchrt.\u00a0Die\u00a0weiteren\u00a0klinischen \u00a0Symptome \u00a0lassen\u00a0sich\u00a0durch\u00a0die\u00a0Einwanderung \u00a0der\u00a0\nT\u2010Zellen\u00a0in\u00a0die\u00a0unterschiedlichen \u00a0Organe\u00a0und\u00a0durch\u00a0die\u00a0erh\u00f6hte\u00a0Konzentration \u00a0der\u00a0Zytokine\u00a0erkl\u00e4ren,\u00a0\ndie\u00a0durch\u00a0T\u2010Zellen\u00a0und\u00a0Makrophagen \u00a0ausgesch\u00fcttet \u00a0werden.\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a09\u00a0von\u00a014\u00a0Diagnostische \u00a0Methoden \u00a0\nBlutuntersuchungen: \u00a0\n\uf0b7 Blutbild\u00a0(H\u00e4moglobin, \u00a0Thrombozyten, \u00a0Leukozyten) \u00a0und\u00a0Blutausstrich \u00a0\n\uf0b7 Entz\u00fcndungswerte \u00a0(CRP,\u00a0l\u00f6sliches\u00a0CD25)\u00a0\n\uf0b7 Leberwerte \u00a0(AST,\u00a0ALT,\u00a0Blutfette) \u00a0\n\uf0b7 Bestimmung \u00a0von\u00a0Gerinnungswerten \u00a0und\u00a0des\u00a0Ferritins\u00a0\n\uf0b7 Wichtig\u00a0sind\u00a0auch\u00a0immunologische \u00a0Blutuntersuchungen, \u00a0bei\u00a0denen\u00a0die\u00a0Zelltoxizit\u00e4t \u00a0von\u00a0\nnat\u00fcrlichen \u00a0Killerzellen \u00a0und\u00a0T\u2010Zellen\u00a0im\u00a0Reagenzglas \u00a0untersucht \u00a0werden\u00a0kann.\u00a0Diese\u00a0\nUntersuchungen \u00a0k\u00f6nnen\u00a0in\u00a0der\u00a0Regel\u00a0einen\u00a0raschen\u00a0Aufschluss \u00a0dar\u00fcber\u00a0geben,\u00a0ob\u00a0eine\u00a0prim\u00e4re\u00a0\noder\u00a0eine\u00a0sekund\u00e4re \u00a0HLH\u00a0vorliegt.\u00a0\u00a0\n\uf0b7 Wenn\u00a0der\u00a0Verdacht\u00a0auf\u00a0eine\u00a0prim\u00e4re\u00a0HLH\u00a0vorliegt,\u00a0werden\u00a0genetische \u00a0Untersuchungen \u00a0\ndurchgef\u00fchrt, \u00a0um\u00a0den\u00a0Verdacht\u00a0zu\u00a0best\u00e4tigen. \u00a0\n\uf0b7 Da\u00a0der\u00a0Ausl\u00f6ser\u00a0f\u00fcr\u00a0einen\u00a0Krankheitsschub \u00a0sowohl\u00a0bei\u00a0den\u00a0angeborenen \u00a0als\u00a0auch\u00a0bei\u00a0den\u00a0\nsekund\u00e4ren \u00a0HLH\u2010Formen\u00a0eine\u00a0Infektion\u00a0sein\u00a0kann,\u00a0sollte\u00a0auch\u00a0immer\u00a0sofort\u00a0nach\u00a0\nKrankheitserregern \u00a0(Viren,\u00a0Bakterien) \u00a0gesucht\u00a0werden.\u00a0\nLumbalpunktion: \u00a0\nAuch\u00a0eine\u00a0Lumbalpunktion \u00a0(Punktion \u00a0zur\u00a0Gewinnung \u00a0von\u00a0Nervenwasser) \u00a0ist\u00a0in\u00a0der\u00a0Regel\u00a0n\u00f6tig.\u00a0Im\u00a0\nNervenwasser \u00a0kann\u00a0h\u00e4ufig\u00a0erh\u00f6htes\u00a0Eiwei\u00df\u00a0und\u00a0erh\u00f6hte\u00a0Zellzahlen \u00a0nachgewiesen \u00a0werden.\u00a0\nKnochenmarkpunktion: \u00a0\nEine\u00a0Knochenmarkpunktion \u00a0ist\u00a0f\u00fcr\u00a0die\u00a0Sicherung \u00a0der\u00a0Diagnose\u00a0und\u00a0f\u00fcr\u00a0den\u00a0Ausschluss \u00a0von\u00a0anderen\u00a0\nErkrankungen \u00a0wie\u00a0Blutkrebs \u00a0(Leuk\u00e4mie), \u00a0die\u00a0sich\u00a0ganz\u00a0\u00e4hnlich\u00a0zeigen\u00a0kann,\u00a0von\u00a0Bedeutung. \u00a0Oft\u00a0sieht\u00a0\nman\u00a0im\u00a0Knochenmark \u00a0H\u00e4mophagozytose, \u00a0dies\u00a0ist\u00a0aber\u00a0nicht\u00a0immer\u00a0der\u00a0Fall.\u00a0\u00a0\nBildgebende \u00a0Verfahren: \u00a0\nZus\u00e4tzliche \u00a0Untersuchungen \u00a0k\u00f6nnen\u00a0bildgebende \u00a0Verfahren \u00a0wie\u00a0ein\u00a0Ultraschall \u00a0des\u00a0Bauchraumes \u00a0\nund\u00a0eine\u00a0Kernspinuntersuchung \u00a0(MRT)\u00a0des\u00a0Kopfes,\u00a0sowie\u00a0ein\u00a0EEG\u00a0(Ableitung \u00a0der\u00a0Hirnstr\u00f6me) \u00a0im\u00a0Falle\u00a0\ndes\u00a0Auftretens \u00a0neurologischer \u00a0Symptome \u00a0sein.\u00a0Die\u00a0Notwendigkeit \u00a0dieser\u00a0Untersuchungen \u00a0richtet\u00a0sich\u00a0\nnach\u00a0den\u00a0vorhandenen \u00a0Krankheitszeichen. \u00a0\u00a0\n\u00a0\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a010\u00a0von\u00a014\u00a0Spezielle\u00a0Diagnostik: \u00a0\nBeim\u00a0Griscelli\u2010\u00a0Syndrom\u00a0und\u00a0beim\u00a0Chediak\u2010Higashi\u00a0Syndrom\u00a0ist\u00a0als\u00a0erg\u00e4nzende \u00a0Diagnostik \u00a0die\u00a0\nMikroskopie \u00a0von\u00a0Haarenschaften \u00a0sinnvoll.\u00a0\u00a0\n\u00a0\n6. Welche\u00a0Behandlungsm\u00f6glichkeiten \u00a0gibt\u00a0es?\u00a0\nDie\u00a0Behandlung \u00a0des\u00a0H\u00e4mophagozytose \u2010Syndroms \u00a0richtet\u00a0sich\u00a0nach\u00a0dem\u00a0Schweregrad \u00a0der\u00a0\nErkrankung. \u00a0Kinder\u00a0mit\u00a0der\u00a0angeborenen \u00a0Form\u00a0m\u00fcssen\u00a0in\u00a0der\u00a0Regel\u00a0intensiver \u00a0behandelt \u00a0werden\u00a0als\u00a0\nKinder\u00a0mit\u00a0der\u00a0erworbenen \u00a0Form.\u00a0\nTherapie\u00a0der\u00a0angeborenen \u00a0H\u00e4mophagozytose \u2010Syndrome: \u00a0\nDie\u00a0Behandlung \u00a0des\u00a0angeborenen \u00a0H\u00e4mophagozytose \u2010Syndroms \u00a0besteht\u00a0aus\u00a0zwei\u00a0Phasen.\u00a0Das\u00a0Ziel\u00a0der\u00a0\nersten\u00a0Behandlungsphase \u00a0ist\u00a0die\u00a0Bek\u00e4mpfung \u00a0des\u00a0akuten\u00a0Krankheitsschubs, \u00a0indem\u00a0man\u00a0mit\u00a0\nbestimmten \u00a0Medikamenten, \u00a0(Immunsuppressiva \u00a0oder\u00a0Chemotherapeutika), \u00a0die\u00a0\u00fcberschie\u00dfende \u00a0\nImmunreaktion \u00a0hemmt.\u00a0Zudem\u00a0soll\u00a0die\u00a0ausl\u00f6sende \u00a0Ursache,\u00a0meist\u00a0eine\u00a0Infektion, \u00a0beseitigt\u00a0und\u00a0einen\u00a0\nR\u00fcckfall\u00a0verhindert \u00a0werden.\u00a0\u00a0\nBei\u00a0der\u00a0prim\u00e4ren \u00a0HLH\u00a0schlie\u00dft\u00a0sich\u00a0eine\u00a0zweite\u00a0Behandlungsphase \u00a0an:\u00a0Sie\u00a0zielt\u00a0auf\u00a0die\u00a0langfristige \u00a0\nHeilung\u00a0der\u00a0genetischen \u00a0Veranlagung \u00a0zur\u00a0HLH.\u00a0Die\u00a0allogene\u00a0h\u00e4matopoietische \u00a0\nStammzelltransplantation \u00a0ist\u00a0aktuell\u00a0die\u00a0einzige\u00a0Behandlungsmethode, \u00a0die\u00a0eine\u00a0langfristige \u00a0Heilung\u00a0\nerzielen\u00a0kann.\u00a0\nImmunsupressive \u00a0Behandlung: \u00a0\nZur\u00a0Unterdr\u00fcckung \u00a0der\u00a0\u00fcberschie\u00dfenden \u00a0Aktivit\u00e4t\u00a0der\u00a0Makrophagen \u00a0und\u00a0T\u2010Zellen\u00a0werden\u00a0\nMedikamente \u00a0gegeben,\u00a0die\u00a0das\u00a0Abwehrsystem \u00a0d\u00e4mpfen. \u00a0Hierzu\u00a0geh\u00f6ren\u00a0in\u00a0der\u00a0Regel\u00a0Kortison,\u00a0\nCyclosporin \u00a0(CSA)\u00a0und\u00a0das\u00a0Zytostatikum \u00a0Etoposid\u00a0(VP16).\u00a0In\u00a0Studien\u00a0werden\u00a0dar\u00fcber\u00a0hinaus\u00a0derzeit\u00a0\nMedikamente \u00a0getestet,\u00a0die\u00a0selektiver \u00a0sind\u00a0als\u00a0Etoposid\u00a0(Campath) \u00a0oder\u00a0die\u00a0Wirkung\u00a0der\u00a0massiv\u00a0\nerh\u00f6hten \u00a0Zytokine\u00a0abschw\u00e4chen \u00a0(anti\u2010Interferon \u2010gamma\u00a0oder\u00a0Ruxolitinib). \u00a0Bei\u00a0der\u00a0prim\u00e4ren \u00a0HLH\u00a0\nmuss\u00a0diese\u00a0intensive\u00a0Therapie\u00a0\u00fcber\u00a0Wochen\u00a0gegeben\u00a0werden,\u00a0bei\u00a0der\u00a0sekund\u00e4ren \u00a0HLH\u00a0kann\u00a0auch\u00a0\neine\u00a0k\u00fcrzere\u00a0Behandlungsdauer \u00a0ausreichen. \u00a0\n\u00a0\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a011\u00a0von\u00a014\u00a0Behandlung \u00a0der\u00a0Infektion: \u00a0\nDa\u00a0Infektionen \u00a0bei\u00a0allen\u00a0Formen\u00a0der\u00a0HLH\u00a0zu\u00a0den\u00a0wichtigsten \u00a0Ausl\u00f6sern \u00a0geh\u00f6ren,\u00a0wird\u00a0fast\u00a0immer\u00a0eine\u00a0\nintensive\u00a0antimikrobielle \u00a0Behandlung, \u00a0inkl.\u00a0Antibiotika \u00a0durchgef\u00fchrt. \u00a0Auch\u00a0Medikamente, \u00a0die\u00a0gegen\u00a0\nViren\u00a0(Virostatika) \u00a0oder\u00a0Pilze\u00a0(Antimykotika) \u00a0gerichtet\u00a0sind,\u00a0kommen\u00a0zum\u00a0Einsatz.\u00a0\nBehandlung \u00a0neurologischer \u00a0Symptome: \u00a0\nFalls\u00a0das\u00a0Kind\u00a0auch\u00a0schwere\u00a0Anzeichen \u00a0einer\u00a0Beteiligung \u00a0des\u00a0Zentralnervensystems \u00a0zeigt,\u00a0so\u00a0wird\u00a0eine\u00a0\nBehandlung \u00a0\u00fcber\u00a0die\u00a0Gabe\u00a0von\u00a0Medikamenten \u00a0in\u00a0das\u00a0Nervenwasser \u00a0mit\u00a0Hilfe\u00a0einer\u00a0Lumbalpunktion \u00a0\nerwogen. \u00a0Es\u00a0k\u00f6nnen\u00a0Kortison\u00a0und\u00a0Methotrexat \u00a0\u2013\u00a0ein\u00a0Zytostatikum \u00a0\u2010\u00a0verabreicht \u00a0werden.\u00a0\u00a0\nErsatz\u00a0von\u00a0Blutbestandteilen \u00a0(Bluttransfusionen): \u00a0\nIm\u00a0Falle\u00a0einer\u00a0schwerwiegenden \u00a0Blutarmut \u00a0(An\u00e4mie)\u00a0und\u00a0eines\u00a0Mangels\u00a0an\u00a0Blutpl\u00e4ttchen \u00a0\n(Thrombozytopenie) \u00a0m\u00fcssen\u00a0diese\u00a0Blutbestandteile \u00a0durch\u00a0Transfusionen \u00a0ersetzt\u00a0werden.\u00a0Wird\u00a0beim\u00a0\nKind\u00a0ein\u00a0verminderter \u00a0H\u00e4moglobinwert \u00a0festgestellt \u00a0und\u00a0treten\u00a0Krankheitszeichen \u00a0einer\u00a0An\u00e4mie\u00a0auf,\u00a0\nso\u00a0kann\u00a0ein\u00a0Ersatz\u00a0fehlender \u00a0roter\u00a0Blutzellen \u00a0(Erythrozyten) \u00a0erforderlich \u00a0sein.\u00a0Blutpl\u00e4ttchen \u00a0\n(Thrombozyten \u00a0)\u00a0sind\u00a0f\u00fcr\u00a0die\u00a0Blutstillung \u00a0verantwortlich. \u00a0Ein\u00a0starker\u00a0Abfall\u00a0der\u00a0Thrombozytenzahl \u00a0(so\u00a0\ngenannte \u00a0Thrombozytopenie) \u00a0bedeutet\u00a0eine\u00a0Blutungsgef\u00e4hrdung. \u00a0\u00a0\nWenn\u00a0die\u00a0Blutgerinnung \u00a0gest\u00f6rt\u00a0ist,\u00a0kann\u00a0der\u00a0Ersatz\u00a0von\u00a0Gerinnungsfaktoren \u00a0durch\u00a0Plasmagaben \u00a0\nnotwendig \u00a0sein.\u00a0\nUnterst\u00fctzende \u00a0(supportive) \u00a0Therapie\u00a0w\u00e4hrend\u00a0der\u00a0Behandlung \u00a0eines\u00a0H\u00e4mophagozytose \u2010\nSyndroms: \u00a0\nUm\u00a0eine\u00a0h\u00e4ufige\u00a0Venenpunktion \u00a0und\u00a0Reizung\u00a0der\u00a0Venen\u00a0zu\u00a0vermeiden, \u00a0ist\u00a0die\u00a0Anlage\u00a0eines\u00a0zentralen \u00a0\nVenenkatheters \u00a0(zentraler \u00a0Venenkatheter \u00a0\u2010\u00a0ZVK)\u00a0sinnvoll.\u00a0Dieser\u00a0kann\u00a0dann\u00a0bei\u00a0komplikationslosem \u00a0\nVerlauf\u00a0f\u00fcr\u00a0die\u00a0gesamte\u00a0Dauer\u00a0der\u00a0Therapie\u00a0liegen\u00a0bleiben.\u00a0\u00a0\nAllogene\u00a0h\u00e4matopoetische \u00a0Stammzelltransplantation: \u00a0\nBei\u00a0der\u00a0prim\u00e4ren \u00a0HLH\u00a0ist\u00a0zur\u00a0dauerhaften \u00a0Heilung\u00a0und\u00a0der\u00a0Verhinderung \u00a0von\u00a0R\u00fcckf\u00e4llen \u00a0eine\u00a0allogene\u00a0\nBlutstammzelltransplantation \u00a0(allogene \u00a0HSZT)\u00a0erforderlich. \u00a0\nBei\u00a0dieser\u00a0Therapie\u00a0erh\u00e4lt\u00a0der\u00a0Patient\u00a0Blutstammzellen \u00a0\u00a0von\u00a0einem\u00a0anderen\u00a0Menschen \u00a0(\"allo\u2010\"\u00a0\nbedeutet\u00a0\"anders\"\u00a0oder\u00a0\"fremd\"). \u00a0Es\u00a0kann\u00a0sich\u00a0dabei\u00a0um\u00a0einen\u00a0Verwandten \u00a0oder\u00a0um\u00a0einen\u00a0Fremden\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a012\u00a0von\u00a014\u00a0handeln\u00a0(je\u00a0nach\u00a0Art\u00a0des\u00a0Spenders \u00a0wird\u00a0von\u00a0Familienspender \u2010\u00a0beziehungsweise \u00a0Fremdspender \u2010\nTransplantation \u00a0gesprochen). \u00a0\nDas\u00a0Prinzip\u00a0ist\u00a0folgendes: \u00a0die\u00a0eigenen,\u00a0genetisch \u00a0defekten\u00a0blutbildenden \u00a0Zellen\u00a0einschlie\u00dflich \u00a0der\u00a0\nImmunzellen \u00a0werden\u00a0zerst\u00f6rt,\u00a0gesunde\u00a0blutbildende \u00a0Stammzellen \u00a0werden\u00a0verabreicht \u00a0und\u00a0aus\u00a0\ndiesen\u00a0kann\u00a0sich\u00a0ein\u00a0neues,\u00a0gesundes \u00a0Immunsystem \u00a0entwickeln. \u00a0Aber\u00a0was\u00a0sich\u00a0konzeptionell \u00a0einfach\u00a0\nanh\u00f6rt,\u00a0ist\u00a0in\u00a0der\u00a0Praxis\u00a0hochkomplexe \u00a0Medizin\u00a0mit\u00a0vielen\u00a0Risiken\u00a0und\u00a0Faktoren, \u00a0die\u00a0ber\u00fccksichtigt \u00a0\nwerden\u00a0m\u00fcssen.\u00a0\u00a0\nZun\u00e4chst\u00a0einmal\u00a0muss\u00a0ein\u00a0geeigneter \u00a0Spender\u00a0gefunden \u00a0werden.\u00a0Optimal\u00a0geeignet\u00a0ist\u00a0ein\u00a0\nGeschwisterspender. \u00a0Bei\u00a0jedem\u00a0Geschwister \u00a0besteht\u00a0nur\u00a0eine\u00a025\u00a0%\u2010ige\u00a0Chance,\u00a0dass\u00a0die\u00a0\nBluteigenschaften \u00a0passen.\u00a0\u00a0\nIn\u00a0Abwesenheit \u00a0eines\u00a0passenden \u00a0Geschwisters \u00a0gibt\u00a0es\u00a0gro\u00dfe\u00a0Spenderbanken, \u00a0mit\u00a0deren\u00a0Hilfe\u00a0es\u00a0meist\u00a0\ngelingt,\u00a0auch\u00a0einen\u00a0unverwandten \u00a0passenden \u00a0Spender\u00a0zu\u00a0finden.\u00a0Eine\u00a0allogene\u00a0HSZT\u00a0mit\u00a0\nStammzellen \u00a0von\u00a0einem\u00a0nicht\u00a0verwandten \u00a0Spender\u00a0(Fremdspender) \u00a0ist\u00a0aufgrund\u00a0der\u00a0geringeren \u00a0\nGewebevertr\u00e4glichkeit \u00a0zwischen\u00a0Spender\u00a0und\u00a0Empf\u00e4nger \u00a0mit\u00a0vergleichsweise \u00a0h\u00f6heren\u00a0Risiken\u00a0\nverbunden. \u00a0\nTherapie\u00a0des\u00a0erworbenen \u00a0H\u00e4mophagozytose \u2010Syndroms: \u00a0\nDa\u00a0bei\u00a0dieser\u00a0Form\u00a0der\u00a0HLH\u00a0keine\u00a0genetische \u00a0Erkrankung \u00a0behandelt \u00a0werden\u00a0muss,\u00a0besteht\u00a0die\u00a0\nTherapie\u00a0in\u00a0erster\u00a0Linie\u00a0in\u00a0der\u00a0Kontrolle\u00a0der\u00a0\u00fcberschie\u00dfenden \u00a0Entz\u00fcndungsreaktion \u00a0und\u00a0der\u00a0\nBeseitigung \u00a0des\u00a0Ausl\u00f6sers: \u00a0Das\u00a0kann\u00a0die\u00a0Behandlung \u00a0der\u00a0Infektion\u00a0(siehe:\u00a0Kapitel\u00a0\nKrankheitsursachen), \u00a0die\u00a0Intensivierung \u00a0der\u00a0Therapie\u00a0der\u00a0entz\u00fcndlichen \u00a0Grundkrankheit, \u00a0oder\u00a0das\u00a0\nAbsetzen\u00a0von\u00a0Medikamenten, \u00a0welche\u00a0das\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0m\u00f6glicherweise \u00a0ausgel\u00f6st \u00a0\nhaben,\u00a0sein.\u00a0Meist\u00a0ist\u00a0aber\u00a0eine\u00a0zus\u00e4tzliche \u00a0immunsuppressive \u00a0Therapie\u00a0(siehe\u00a0oben)\u00a0notwendig, \u00a0\nklassischerweise \u00a0wird\u00a0auch\u00a0hier\u00a0eine\u00a0Kombinationstherapie \u00a0aus\u00a0Kortison\u00a0und\u00a0Cyclosporin \u00a0A\u00a0\neingesetzt, \u00a0\u00f6fter\u00a0ist\u00a0auch\u00a0das\u00a0Chemotherapeutikum \u00a0Etoposid\u00a0n\u00f6tig.\u00a0Die\u00a0immunsuppressive \u00a0\nBehandlung \u00a0ist\u00a0dann\u00a0aber\u00a0meist\u00a0nur\u00a0vor\u00fcbergehend \u00a0n\u00f6tig\u00a0und\u00a0das\u00a0Risiko\u00a0eines\u00a0R\u00fcckfalls\u00a0ist\u00a0gering.\u00a0\u00a0\n\u00a0\n7. Wie\u00a0sieht\u00a0die\u00a0langfristige \u00a0Entwicklung \u00a0aus\u00a0(Prognose)? \u00a0\nBei\u00a0Patienten \u00a0mit\u00a0einem\u00a0angeborenen \u00a0HLH\u00a0gelingt\u00a0es\u00a0oft,\u00a0mit\u00a0der\u00a0intensiven \u00a0Immunsuppression \u00a0den\u00a0\nakuten\u00a0Schub\u00a0einer\u00a0HLH\u00a0erfolgreich \u00a0zu\u00a0behandeln. \u00a0Wird\u00a0dann\u00a0ein\u00a0geeigneter \u00a0Spender\u00a0f\u00fcr\u00a0die\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a013\u00a0von\u00a014\u00a0h\u00e4matopoetische \u00a0Stammzelltransplantation \u00a0gefunden \u00a0und\u00a0diese\u00a0erfolgreich \u00a0durchgef\u00fchrt, \u00a0sind\u00a0die\u00a0\nlangfristigen \u00a0Heilungschancen \u00a0bei\u00a0der\u00a0prim\u00e4ren \u00a0HLH\u00a0hoch.\u00a0Leider\u00a0gelingt\u00a0es\u00a0aber\u00a0nicht,\u00a0allen\u00a0Kindern\u00a0\nzu\u00a0helfen.\u00a0Wenn\u00a0die\u00a0Erkrankung \u00a0zu\u00a0sp\u00e4t\u00a0erkannt\u00a0wird,\u00a0sich\u00a0die\u00a0Entz\u00fcndung \u00a0nicht\u00a0kontrollieren \u00a0l\u00e4sst\u00a0\noder\u00a0w\u00e4hrend\u00a0der\u00a0schweren \u00a0Immunsuppression \u00a0oder\u00a0der\u00a0HSZT\u00a0Komplikationen \u00a0auftreten, \u00a0kann\u00a0trotz\u00a0\naller\u00a0medizinscher \u00a0Ma\u00dfnahmen \u00a0die\u00a0Erkrankung \u00a0zum\u00a0Tod\u00a0f\u00fchren.\u00a0\nDie\u00a0Prognose \u00a0der\u00a0sekund\u00e4ren \u00a0HLH\u00a0ist\u00a0nach\u00a0der\u00a0Behandlung \u00a0der\u00a0urs\u00e4chlich \u00a0ausl\u00f6senden \u00a0Erkrankung \u00a0\ngut.\u00a0Auch\u00a0die\u00a0sekund\u00e4re \u00a0HLH\u00a0ist\u00a0eine\u00a0ernste\u00a0Erkrankung, \u00a0aber\u00a0schwere\u00a0Verl\u00e4ufe\u00a0sind\u00a0seltener.\u00a0Es\u00a0\nkann\u00a0zu\u00a0R\u00fcckf\u00e4llen \u00a0kommen, \u00a0wenn\u00a0die\u00a0Grunderkrankung \u00a0(z.B.\u00a0schweres \u00a0Rheuma)\u00a0nicht\u00a0zur\u00a0Ruhe\u00a0\nkommt,\u00a0aber\u00a0eine\u00a0Stammzelltransplantation \u00a0ist\u00a0in\u00a0der\u00a0Regel\u00a0nicht\u00a0erforderlich. \u00a0\n\u00a0\n8. Sind\u00a0Impfungen \u00a0erlaubt?\u00a0\nWenn\u00a0die\u00a0Diagnose\u00a0einer\u00a0angeborenen \u00a0HLH\u00a0gestellt\u00a0wird,\u00a0sollten\u00a0Impfungen \u00a0nicht\u00a0durchgef\u00fchrt \u00a0\nwerden,\u00a0da\u00a0sie\u00a0unter\u00a0Umst\u00e4nden \u00a0einen\u00a0Schub\u00a0der\u00a0Erkrankung \u00a0ausl\u00f6sen\u00a0k\u00f6nnen.\u00a0Nach\u00a0Erholung\u00a0von\u00a0\neiner\u00a0erworbenen \u00a0HLH\u00a0muss\u00a0der\u00a0richtige\u00a0Zeitpunkt \u00a0besprochen \u00a0werden,\u00a0Impfungen \u00a0sollten\u00a0aber\u00a0im\u00a0\nPrinzip\u00a0durchgef\u00fchrt \u00a0werden.\u00a0Dies\u00a0gilt\u00a0auch\u00a0f\u00fcr\u00a0Kinder\u00a0mit\u00a0angeborener \u00a0HLH\u00a0nach\u00a0erfolgreicher \u00a0\nStammzelltransplantation. \u00a0\n\u00a0\n9. Kann\u00a0das\u00a0Kind\u00a0in\u00a0den\u00a0Kindergarten/ \u00a0die\u00a0Schule\u00a0gehen?\u00a0\nKinder\u00a0mit\u00a0der\u00a0schweren \u00a0angeborenen \u00a0Form\u00a0der\u00a0Erkrankung \u00a0k\u00f6nnen\u00a0nach\u00a0einer\u00a0erfolgreichen \u00a0\nStammzelltransplantation \u00a0(wieder)\u00a0Kindergarten \u00a0und\u00a0Schule\u00a0besuchen. \u00a0Kinder\u00a0mit\u00a0Varianten \u00a0der\u00a0\nErkrankung \u00a0oder\u00a0der\u00a0erworbenen \u00a0Form\u00a0der\u00a0HLH\u00a0k\u00f6nnen\u00a0ebenfalls\u00a0nach\u00a0erfolgreicher \u00a0Therapie\u00a0wieder\u00a0\nin\u00a0den\u00a0Kindergarten \u00a0oder\u00a0die\u00a0Schule\u00a0gehen.\u00a0\n\u00a0\u00a0H\u00e4mophagozytose \u2010Syndrom\u00a0(HLH)\u00a0\nSeite\u00a014\u00a0von\u00a014\u00a0Hinweis\u00a0\nWir\u00a0m\u00f6chten\u00a0mit\u00a0unseren\u00a0Patienten \u2010Informationsbrosch\u00fcren \u00a0gerne\u00a0dazu\u00a0beitragen, \u00a0dass\u00a0betroffene \u00a0Patienten, \u00a0\nEltern\u00a0und\u00a0ihr\u00a0Umfeld\u00a0die\u00a0Erkrankung \u00a0und\u00a0ihre\u00a0Behandlung \u00a0besser\u00a0verstehen. \u00a0Die\u00a0Brosch\u00fcren \u00a0sind\u00a0sorgf\u00e4ltig \u00a0\nerstellt\u00a0und\u00a0beschreiben \u00a0die\u00a0Erkrankung \u00a0und\u00a0deren\u00a0Behandlung. \u00a0Auch\u00a0wenn\u00a0Sie\u00a0viele\u00a0Informationen \u00a0in\u00a0den\u00a0\nBrosch\u00fcren \u00a0finden,\u00a0k\u00f6nnen\u00a0diese\u00a0vorliegenden \u00a0Informationen \u00a0keinen\u00a0Arztbesuch \u00a0ersetzen.\u00a0\nReferenzen \u00a0\nEhl\u00a0S,\u00a0Astigarraga \u00a0I,\u00a0von\u00a0Bahr\u00a0Greenwood \u00a0T,\u00a0Hines\u00a0M,\u00a0Horne\u00a0A,\u00a0Ishii\u00a0E,\u00a0Janka\u00a0G,\u00a0Jordan\u00a0MB,\u00a0La\u00a0Ros\u00e9e\u00a0P,\u00a0\nLehmberg \u00a0K,\u00a0Machowicz \u00a0R,\u00a0Nichols\u00a0KE,\u00a0Sieni\u00a0E,\u00a0Wang\u00a0Z,\u00a0Henter\u00a0JI.\u00a0Recommendations \u00a0for\u00a0the\u00a0Use\u00a0of\u00a0Etoposide \u2010\nBased\u00a0Therapy\u00a0and\u00a0Bone\u00a0Marrow\u00a0Transplantation \u00a0for\u00a0the\u00a0Treatment \u00a0of\u00a0HLH:\u00a0Consensus \u00a0Statements \u00a0by\u00a0the\u00a0HLH\u00a0\nSteering\u00a0Committee \u00a0of\u00a0the\u00a0Histiocyte \u00a0Society.\u00a0J\u00a0Allergy\u00a0Clin\u00a0Immunol\u00a0Pract.\u00a02018\u00a0Sep\u00a0\u2010\u00a0Oct;6(5):1508 \u20101517.\u00a0\nSepulveda \u00a0FE,\u00a0de\u00a0Saint\u00a0Basile\u00a0G.\u00a0Hemophagocytic \u00a0syndrome: \u00a0primary\u00a0forms\u00a0and\u00a0predisposing \u00a0conditions. \u00a0Curr\u00a0\nOpin\u00a0Immunol. \u00a02017\u00a0Dec;49:20 \u201026.\u00a0\u00a0\nJanka\u00a0GE,\u00a0Lehmberg \u00a0K.\u00a0Hemophagocytic \u00a0syndromes \u2010\u2010an\u00a0update.\u00a0Blood\u00a0Rev.\u00a02014\u00a0Jul;28(4):135 \u201042.\u00a0\nAutor\u00a0\nHenrike\u00a0Ritterbusch \u00a0\n+49\u00a0(0)761\u00a0270\u201045240\u00a0\nhenrike.ritterbusch@uniklinik \u2010freiburg.de \u00a0\nWissenschaftliche \u00a0Begleitung \u00a0\nProf.\u00a0Dr.\u00a0Stephan\u00a0Ehl\u00a0\n+49\u00a0(0)761\u00a0270\u201077300\u00a0\nstephan.ehl@uniklinik \u2010freiburg.de \u00a0\nUNIVERSIT\u00c4TSKLINIKUM \u00a0FREIBURG \u00a0\nCentrum\u00a0f\u00fcr\u00a0Chronische \u00a0Immundefizienz \u00a0\nMathildenstra\u00dfe \u00a01\u00a0\n79106\u00a0Freiburg\u00a0\nwww.uniklinik \u2010freiburg.de/cci \u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Stand:\u00a0Oktober\u00a02019\u00a0", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}